Qube Research & Technologies (QRT)
ZVRA icon

Qube Research & Technologies (QRT)’s Zevra Therapeutics ZVRA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.85M Buy
842,319
+486,076
+136% +$4.38M 0.01% 1426
2025
Q4 		$3.19M Buy
356,243
+49,754
+16% +$471K ﹤0.01% 2012
2025
Q3 		$2.91M Buy
306,489
+295,201
+2,615% +$2.96M ﹤0.01% 2043
2025
Q2 		$99.4K Buy
+11,288
New +$91.6K ﹤0.01% 3036
2023
Q1 		– Sell
-30,259
Closed -$139K – 3123
2022
Q4 		$139K Buy
30,259
+8,426
+39% +$42.8K ﹤0.01% 1920
2022
Q3 		$136K Sell
21,833
-3,017
-12% -$17.1K ﹤0.01% 1885
2022
Q2 		$111K Buy
+24,850
New +$113K ﹤0.01% 1908

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return